CENTOGENE N.V. (CNTG): Price and Financial Metrics
CNTG Price/Volume Stats
| Current price | $0.33 | 52-week high | $1.53 |
| Prev. close | $0.35 | 52-week low | $0.25 |
| Day low | $0.32 | Volume | 8,358,200 |
| Day high | $0.43 | Avg. volume | 150,868 |
| 50-day MA | $0.40 | Dividend yield | N/A |
| 200-day MA | $0.78 | Market Cap | 8.80M |
CNTG Stock Price Chart Interactive Chart >
CENTOGENE N.V. (CNTG) Company Bio
Centogene NV is a commercial-stage company. It focuses on rare diseases that transform real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. It operates through the following two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment provides services to pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery and patient monitoring. The Diagnostics segment provides targeted genetic sequencing and diagnostics services. The company was founded by Arndt Rolf and Christoph Ehlers in 2006 and is headquartered in Rostock, Denmark.
CNTG Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | -11.76% |
| 1-year | -72.50% |
| 3-year | -96.28% |
| 5-year | -97.53% |
| YTD | -72.50% |
| 2023 | 29.03% |
| 2022 | -82.21% |
| 2021 | -51.50% |
| 2020 | 7.05% |
| 2019 | N/A |
Loading social stream, please wait...